Novartis’ long-awaited separation from its eye care division Alcon completed on schedule today, allowing it to focus its energies on medicinal products. Alcon’s shares made their debut on the ...

TOKYO -- Swiss pharmaceutical company Novartis has pegged its cancer-targeting radiopharmaceutical business as its next growth pillar, looking to make it "at least a $10 billion business" over the ...

TPG-backed ophthalmology specialist BVI Medical will use the investment to fund new product launches and scale its operations ...

Novartis is one of the world's top pharmaceutical ... the company's main focus – while the rest are split between Alcon, Sandoz, Vaccines and Diagnostics, Consumer Health, Shared services ...

Novartis tumbled 5.6%. Roche Holding and Kuehne + Nagel both closed lower by about 3.5% Straumann Holding, Schindler Ps, Alcon, UBS Group, SIG Group, Lindt & Spruengli, Nestle and SGS lost 2 to 3.1%.

Schindler Ps, Swisscom, Novartis and Roche climbed 1.4 to 1.7% ... Swatch Group ended down 3.15% and Geberit closed 2.1% down. Alcon ended nearly 2% down. Adecco and Sika closed lower by 1. ...

The table is limited by our hospital pharmacy's formulary; however, our purpose was to update the current literature. The table is intended for use as a guide when medications labeled for ...

After hours: March 11 at 7:58:21 PM EDT Loading Chart for NVS ...

Swiss Life Holding AG CHF781.40 10.20 1.32% ...